TuHURA Biosciences, Inc.
HURA
$3.22
$0.3110.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.99M | 5.73M | 4.31M | 3.35M | 3.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.42M | 20.06M | 17.65M | 14.61M | 15.44M |
| Operating Income | -22.42M | -20.06M | -17.65M | -14.61M | -15.44M |
| Income Before Tax | -27.76M | -23.50M | -21.68M | -18.37M | -17.33M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.76 | -23.50 | -21.68 | -18.37 | -17.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.76M | -23.50M | -21.68M | -18.37M | -17.33M |
| EBIT | -22.42M | -20.06M | -17.65M | -14.61M | -15.44M |
| EBITDA | -22.34M | -19.96M | -17.53M | -14.47M | -15.29M |
| EPS Basic | -0.59 | -0.81 | -1.06 | -0.96 | -0.87 |
| Normalized Basic EPS | -0.31 | -0.50 | -0.65 | -0.59 | -0.54 |
| EPS Diluted | -0.59 | -0.81 | -1.06 | -0.96 | -0.87 |
| Normalized Diluted EPS | -0.31 | -0.50 | -0.65 | -0.59 | -0.54 |
| Average Basic Shares Outstanding | 206.65M | 174.27M | 143.04M | 168.73M | 92.37M |
| Average Diluted Shares Outstanding | 206.65M | 174.27M | 143.04M | 168.73M | 92.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.01% | -0.01% | -- | -- | -- |